PharmaResearch signs EUR 54.5 million distribution partnership with VIVACY for Rejuran in Europe

PharmaResearch announced a strategic partnership agreement with VIVACY to distribute its medical device brand Rejuran in the European market. The agreement is valued at approximately EUR 54.5 million over 5 years and spans 22 countries.

“PharmaResearch announced the signing of a strategic partnership agreement with VIVACY to distribute its medical device brand Rejuran in the European market.”marketscreener.com

• 1 source
• marketscreener.comPharma Research Establishes European Distribution Partnership for 'Rejuran' | MarketScreenerS&P Capital IQAug 29, 2025

Summarized from public sources; check the original articles before acting on it.